BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1910437)

  • 1. Treatment of pure red-cell aplasia following major ABO-mismatched T-cell-depleted bone marrow transplantation. Two case reports with successful response to plasmapheresis.
    Or R; Naparstek E; Mani N; Slavin S
    Transpl Int; 1991 Jun; 4(2):99-102. PubMed ID: 1910437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apheresis therapy for prolonged red cell aplasia after major ABO-mismatched bone marrow transplantation.
    Ohta S; Yokoyama H; Ise T; Takasawa K; Wada T; Nakao S; Matsuda T; Kobayashi K
    Intern Med; 1997 Jul; 36(7):487-91. PubMed ID: 9240498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
    Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
    Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
    Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
    Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure red cell aplasia after major ABO-incompatible bone marrow transplantation: two case reports of treatment with recombinant human erythropoietin.
    Fujisawa S; Maruta A; Sakai R; Taguchi J; Tomita N; Ogawa K; Kodama F; Takahashi K; Shibayama S; Kobayashi S; Ikuta K; Okubo T
    Transpl Int; 1996; 9(5):506-8. PubMed ID: 8875795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: response to antithymocyte globulin.
    Bierman PJ; Warkentin P; Hutchins MR; Klassen LW
    Leuk Lymphoma; 1993 Jan; 9(1-2):169-71. PubMed ID: 8477196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of double-filtration plasmapheresis in major ABO-incompatible unrelated bone marrow transplantation].
    Huang T; Sun J; Liu J; Liu QF; Men FY
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1438-40. PubMed ID: 16305976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
    Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
    Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure red-cell aplasia of long duration after major ABO-incompatible bone marrow transplantation.
    Volin L; Ruutu T
    Acta Haematol; 1990; 84(4):195-7. PubMed ID: 2125785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure red cell aplasia after ABO major-mismatched allogeneic peripheral blood stem cell transplantation successfully treated with plasma exchange and low-dose steroid: two case reports.
    Tsai HJ; Lin SF; Liu TC; Chang CS; Hsiao HH; Chen TP
    Kaohsiung J Med Sci; 2004 Mar; 20(3):128-32. PubMed ID: 15124897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion.
    Verholen F; Stalder M; Helg C; Chalandon Y
    Eur J Haematol; 2004 Dec; 73(6):441-6. PubMed ID: 15522068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure red cell aplasia following ABO-incompatible bone marrow transplantation: response to erythropoietin.
    Paltiel O; Cournoyer D; Rybka W
    Transfusion; 1993 May; 33(5):418-21. PubMed ID: 8488547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplantation Team.
    Ohashi K; Akiyama H; Takamoto S; Tanikawa S; Sakamaki H; Onozawa Y
    Bone Marrow Transplant; 1994 Mar; 13(3):335-6. PubMed ID: 8199576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin.
    Roychowdhury DF; Linker CA
    Bone Marrow Transplant; 1995 Sep; 16(3):471-2. PubMed ID: 8535322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant.
    Sackett K; Cohn CS; Fahey-Ahrndt K; Smith AR; Johnson AD
    J Clin Apher; 2018 Feb; 33(1):108-112. PubMed ID: 28543448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
    Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
    Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant.
    Labar B; Bogdanić V; Nemet D; Kovacević-Metelko J; Mrsić M; Pavletić Z; Zupancić-Salek S; Radman I; Aurer I
    Bone Marrow Transplant; 1992 Nov; 10(5):471-2. PubMed ID: 1464014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long duration of erythrocyte hypoplasia after bone marrow transplantation.
    Suzuki N; Kudoh T; Katoh S; Yohtoh Y; Miura J; Kamimura S; Sakuma Y; Fujita S; Chiba S
    Acta Paediatr Jpn; 1992 Aug; 34(4):473-5. PubMed ID: 1414339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation.
    Tomac G; Bojanić I; Mazić S; Vidović I; Raos M; Ćepulić BG; Seiwerth RS; Kelečić J; Labar B
    Blood Transfus; 2018 Jul; 16(4):397-404. PubMed ID: 28488966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pure red cell aplasia after a major ABO-mismatched bone marrow transplant for chronic myeloid leukaemia: response to re-introduction of cyclosporin.
    Hayden PJ; Gardiner N; Molloy K; Ryan J; Lawler M; McCann SR
    Bone Marrow Transplant; 2004 Feb; 33(4):459-61. PubMed ID: 14676777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.